JPS6366518B2 - - Google Patents
Info
- Publication number
- JPS6366518B2 JPS6366518B2 JP14634880A JP14634880A JPS6366518B2 JP S6366518 B2 JPS6366518 B2 JP S6366518B2 JP 14634880 A JP14634880 A JP 14634880A JP 14634880 A JP14634880 A JP 14634880A JP S6366518 B2 JPS6366518 B2 JP S6366518B2
- Authority
- JP
- Japan
- Prior art keywords
- medium
- bifidobacterium
- acid
- solution
- selective medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000006152 selective media Substances 0.000 claims description 17
- 241000186000 Bifidobacterium Species 0.000 claims description 14
- 239000002609 medium Substances 0.000 claims description 10
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 235000000346 sugar Nutrition 0.000 claims description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 150000003863 ammonium salts Chemical class 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 claims description 4
- 229960000210 nalidixic acid Drugs 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- 235000019192 riboflavin Nutrition 0.000 claims description 4
- 239000002151 riboflavin Substances 0.000 claims description 4
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 3
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 150000008163 sugars Chemical class 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 229940055726 pantothenic acid Drugs 0.000 claims description 2
- 235000019161 pantothenic acid Nutrition 0.000 claims description 2
- 239000011713 pantothenic acid Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 10
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229960002433 cysteine Drugs 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000012533 medium component Substances 0.000 description 3
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- ABIUHPWEYMSGSR-UHFFFAOYSA-N bromocresol purple Chemical compound BrC1=C(O)C(C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C=C(Br)C(O)=C(C)C=2)=C1 ABIUHPWEYMSGSR-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 229960001305 cysteine hydrochloride Drugs 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000007793 ph indicator Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229940076788 pyruvate Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 235000020244 animal milk Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本発明はビフイドバクテリウム菌の選択培地に
関するものである。
腸内容物や糞便などの生体由来材料あるいはビ
フイドバクテリウム菌を含有する飲食品から、試
験・研究の目的でその中のビフイドバクテリウム
菌のみを取り出して培養したい場合、この菌のみ
を選択的に増殖させて他の菌は増殖させないか著
しく増殖を抑制する性質を持つ培地、すなわち選
択培地を利用することが多い。
しかしながら、もともとビフイドバクテリウム
菌は培養が比較的困難なものであるから、選択性
を強化するとこの菌の増殖まで抑制されてしまう
ことが多く、したがつて従来のビフイドバクテリ
ウム菌の選択培地は選択性においてやや不十分で
あるという欠点があつた。
本発明の目的は、各種のビフイドバクテリウム
菌を旺盛に増殖させる一方、他の菌の増殖は強く
抑制する能力を持つ、よりすぐれたビフイドバク
テリウム菌の選択培地を提供することにある。
この目的を達成することに成功した本発明は、
ビフイドバクテリウム菌の選択培地としてグルコ
ース、ラクトース、フラクトースからなる群から
選ばれた糖、アンモニウム塩、ビオチン、バント
テン酸、リボフラビン、ピルビン酸、ポリオキシ
エチレンソルビタンモノ脂肪酸エステル及びナリ
ジクス酸を含有する完全合成培地を選定したこと
を特徴とする。
上記の各培地成分はビフイドバクテリウム菌の
選択的増殖のための必須成分であつて、それらの
いずれを欠いても良好な選択培地とはならない。
これらのほかに、本発明の選択培地には通常ビフ
イドバクテリウム菌の培地に添加される無機栄養
塩類が還元剤(アスコルビン酸やシステインな
ど)を含有させるとよく、更にビフイドバクテリ
ウム菌の増殖促進に有効な物質、例えばロイシ
ン、バリン、メチオニン、システインン等のアミ
ノ酸、アデニン、グアニン、キサンチン、ウラシ
ル等の核酸塩基、グルコサミンを含むオリゴ糖、
例えばβ―エチル―N―アセチル―D―グルコサ
ミナイド等を、他の菌の増殖抑制に不都合を生じ
ない範囲で含有させてもよい。
一方、本発明の選択培地に含有させるとビフイ
ドバクテリウム菌以外の菌を増殖させる為本発明
の培地に添加してはならない物質の例としては、
獣乳、肉汁、酵母エキス、トリプチケースあるい
はこれらに近いアミノ酸構成を持つアミノ酸混合
物がある。
本発明の選択培地における前記必須成分の含有
量は、培地100ml当り次の範囲内にあることが望
ましい。
糖類(総量) 1.0〜3.5g
アンモニウム塩(硫安として) 0.5〜2.0g
ビオチン 0.01〜0.10mg
パントテン酸 0.2〜1.0mg
リボフラビン 0.1〜1.0mg
ピルビン酸 5〜20mg
ポリオキシエチレンソルビタンモノ脂肪酸ス
テル(Tween 80として) 0.5〜0.1g
ナリジクス酸 5〜10mg
これら以外の培地成分の含有量は、他の菌の増
殖抑制に不都合を生じない範囲で適宜選定すれば
よい。具体例を示すと、核酸塩基10〜50mg、アミ
ノ酸類10〜50mg、各種オリゴ糖1〜2gである。
なお菌の増殖には関係がないが、培地の嫌気状
態の指示薬であるレサズリン、コロニーの識別の
ためのPH指示薬であるブロムクレゾールパープル
等を培地に含有させてもよい。
本発明の選択培地を調製するには、所定量の塩
類溶液、レサズリン、糖、アンモニウム塩、
Tween80、および寒天を水に溶解後、ビタミン
類、ピルビン酸、システイン、ナリジクス酸を順
次加える。最後に炭酸ソーダを加えて、ガス噴射
法(嫌気ロールチユーブ法)により炭酸ガスバブ
リングを行い溶存酸素を置換する。培地が還元さ
れた時点で(レサズリンが脱色し、リボフラビン
の黄色が鮮明になる)、PH指示薬であるブロムク
レゾールパープルを加えて炭酸ガス下で試験管に
分注する。完全に嫌気的かつ単準な合成培地なの
で、滅菌は100℃、30分、1回で充分である。冷
却後は冷暗所に保存する。
通常の嫌気ジヤー法の場合(平板培地として使
用する場合)は、炭酸ガスバブリングをせず、ま
た上記組成からレサズリン、炭酸ソーダを除い
て、上記の順序で溶解し、滅菌後分注する。使用
に際しては常に新鮮培地を用意することが望まし
い。本発明の選択培地を用いる選択培養には、嫌
気ロールチユーブ法、嫌気ジヤー法共に通常37
℃、5日間の培養数が必要である。但し、嫌気ジ
ヤー法では、ロールチユーブ法に比し嫌気条件が
悪いことから菌種によつては若干増殖が遅れるこ
とがある。
以下実施例及び実験例を示して本発明を説明す
る。
実施例 1
The present invention relates to a selective medium for Bifidobacterium. If you want to extract and culture only the Bifidobacterium bacteria from biological materials such as intestinal contents and feces, or food and beverages containing Bifidobacterium bacteria for the purpose of testing or research, select only this bacterium. In many cases, a selective medium is used, which allows for the growth of other bacteria while preventing or significantly suppressing the growth of other bacteria. However, since Bifidobacterium is originally relatively difficult to culture, enhancing selectivity often inhibits the growth of this bacterium. The medium had the disadvantage of being somewhat unsatisfactory in selectivity. An object of the present invention is to provide a superior selective medium for Bifidobacterium that has the ability to actively propagate various Bifidobacterium bacteria while strongly suppressing the growth of other bacteria. . The present invention has succeeded in achieving this objective.
A selective medium for Bifidobacterium containing a sugar selected from the group consisting of glucose, lactose, fructose, ammonium salt, biotin, bantothenic acid, riboflavin, pyruvate, polyoxyethylene sorbitan monofatty acid ester, and nalidixic acid. It is characterized by the selection of a synthetic medium. Each of the above-mentioned medium components is an essential component for the selective growth of Bifidobacterium, and a good selective medium cannot be obtained without any of them.
In addition to these, the selective medium of the present invention preferably contains reducing agents (such as ascorbic acid and cysteine), as well as inorganic nutrient salts that are normally added to Bifidobacterium cultures. Substances effective for promoting proliferation, such as amino acids such as leucine, valine, methionine, and cysteine, nucleobases such as adenine, guanine, xanthine, and uracil, oligosaccharides containing glucosamine,
For example, β-ethyl-N-acetyl-D-glucosaminide and the like may be contained within a range that does not cause any inconvenience in inhibiting the growth of other bacteria. On the other hand, examples of substances that should not be added to the selective medium of the present invention because they cause the growth of bacteria other than Bifidobacterium include:
There are animal milk, meat juice, yeast extract, trypticase, or an amino acid mixture with an amino acid composition similar to these. The content of the essential components in the selective medium of the present invention is preferably within the following range per 100 ml of medium. Sugars (total) 1.0-3.5g Ammonium salt (as ammonium sulfate) 0.5-2.0g Biotin 0.01-0.10mg Pantothenic acid 0.2-1.0mg Riboflavin 0.1-1.0mg Pyruvate 5-20mg Polyoxyethylene sorbitan monofatty acid ster (as Tween 80) ) 0.5 to 0.1 g Nalidixic acid 5 to 10 mg The contents of other medium components may be appropriately selected within a range that does not cause any inconvenience in suppressing the growth of other bacteria. Specific examples include 10 to 50 mg of nucleic acid bases, 10 to 50 mg of amino acids, and 1 to 2 g of various oligosaccharides. Although not related to bacterial growth, the medium may contain resazurin, an indicator for the anaerobic state of the medium, bromcresol purple, a PH indicator for colony identification, and the like. To prepare the selective medium of the present invention, a predetermined amount of saline, resazurin, sugar, ammonium salt,
After dissolving Tween 80 and agar in water, vitamins, pyruvic acid, cysteine, and nalidixic acid are sequentially added. Finally, soda carbonate is added and carbon dioxide gas is bubbled by a gas injection method (anaerobic roll tube method) to replace dissolved oxygen. When the medium is reduced (resazurin decolorizes and riboflavin becomes bright yellow), add bromcresol purple, a PH indicator, and dispense into test tubes under carbon dioxide gas. Since it is a completely anaerobic and simple synthetic medium, sterilization at 100°C for 30 minutes is sufficient. After cooling, store in a cool dark place. In the case of the normal anaerobic jar method (when used as a plate culture medium), carbon dioxide gas is not bubbled, and resazurin and soda carbonate are removed from the above composition, dissolved in the above order, and dispensed after sterilization. It is desirable to always have a fresh medium available for use. For selective culture using the selective culture medium of the present invention, both the anaerobic roll tube method and the anaerobic jar method are usually used.
℃, 5 days of culture is required. However, in the anaerobic jar method, the anaerobic conditions are poorer than in the roll tube method, so depending on the bacterial species, growth may be slightly delayed. The present invention will be explained below with reference to Examples and Experimental Examples. Example 1
【表】
酸素を含まない炭酸ガスを吹込みながら上記培
地成分を蒸留水に溶かし、次いでPHを6.8に調整
してから全量を100mlとする。これを再び炭酸ガ
スを吹込みながら5mlずつロールチユーブにと
り、100℃で30分間殺菌後、5℃に冷却して使用
迄同温度で保存する。
実験例 1
健康な成人8名の糞便をそれぞれ後記組成の希
釈液を用いて108〜109倍に嫌気的に希釈し、得ら
れた希釈液0.5mlを実施例1の選択培地に接種し、
37℃で5日間培養した。培養終了後、嫌気ロール
チーブ上に出現したコロニーを分離し、光岡らの
方法(Am.J.Clin.Nutrition,30,1799,1977)
により嫌気性菌であることを確認し、更に形態、
グラム染色性、グルコースから産生する酸の種
類、各種糖の発酵性などから菌種を同定した。
その結果を表1に示す。表中、コロニー数は8
試料についての合計値である。
出現した75株中、71株(95%)がビフイドバク
テリウム菌であり、本培地の強い選択性が確認さ
れた。[Table] Dissolve the above medium components in distilled water while blowing oxygen-free carbon dioxide gas, then adjust the pH to 6.8 and make the total volume 100 ml. Transfer 5 ml of this into a roll tube while blowing carbon dioxide gas again, sterilize it at 100°C for 30 minutes, cool it to 5°C, and store at the same temperature until use. Experimental Example 1 The feces of eight healthy adults were anaerobically diluted 10 8 to 10 9 times using a diluent having the composition shown below, and 0.5 ml of the obtained diluted solution was inoculated into the selective medium of Example 1. ,
The cells were cultured at 37°C for 5 days. After culturing, isolate the colonies that appeared on the anaerobic roll tube and follow the method of Mitsuoka et al. (Am.J.Clin.Nutrition, 30 , 1799, 1977).
It was confirmed that it was an anaerobic bacterium, and the morphology and
The bacterial species was identified based on Gram staining, the type of acid produced from glucose, and the ability to ferment various sugars. The results are shown in Table 1. In the table, the number of colonies is 8
This is the total value for the sample. Of the 75 strains that appeared, 71 (95%) were Bifidobacterium, confirming the strong selectivity of this medium.
0.1%K2HPO4溶液 7.5ml
溶液* 7.5ml
0.1レサズリン溶液 0.1ml
10%Na2CO3溶液 3ml
5%システイン塩酸塩溶液 1ml
蒸留水 81ml
(PH 6.8)
※ 溶液組成
KH2PO4 0.6%
(NH4)2SO4 1.2%
NaCl 1.2%
MgSO4・7H2O 0.12%
CaCl2・2H2O 0.12%
実験例 2
実験例1で調製したものと同じ糞便希釈液各
0.5mlを実験例1で用いたものと同じ選択培地及
び対照用の後記組成の非選択培地に接種して37℃
で5日間培養した。培養終了後、各培地に形成さ
れたビフイドバクテリウム菌のコロニーを実験例
1の場合と同様にして確認、計数し、糞便1g当
りの菌数に換算した。
その結果を表2に示す。本発明の選択培地を用
いた場合と非選択培地を用いた場合とで結果に有
意差はなく、このことから本発明の選択培地が試
料中のビフイドバクテリウム菌の定量的分離や計
測に利用できることがわかる。
0.1% K 2 HPO 4 solution 7.5 ml Solution * 7.5 ml 0.1 Resazurin solution 0.1 ml 10% Na 2 CO 3 solution 3 ml 5% Cysteine hydrochloride solution 1 ml Distilled water 81 ml (PH 6.8) * Solution composition KH 2 PO 4 0.6% ( NH 4 ) 2 SO 4 1.2% NaCl 1.2% MgSO 4・7H 2 O 0.12% CaCl 2・2H 2 O 0.12% Experimental Example 2 The same diluted feces as that prepared in Experimental Example 1
0.5 ml was inoculated into the same selective medium used in Experimental Example 1 and a non-selective medium with the composition shown below for control, and the mixture was incubated at 37°C.
The cells were cultured for 5 days. After the culture was completed, Bifidobacterium colonies formed in each medium were confirmed and counted in the same manner as in Experimental Example 1, and the number was converted to the number of bacteria per 1 g of feces. The results are shown in Table 2. There is no significant difference in the results between using the selective medium of the present invention and when using a non-selective medium, which indicates that the selective medium of the present invention is suitable for quantitative isolation and measurement of Bifidobacterium in samples. I know it can be used.
グルコース 0.2g 牛肉エキス(BBL) 0.2g 酵母エキス(Difco) 0.5g トリブテイケース(BBL) 1g 0.1%K2HPO4溶液 7.5ml 溶液I* 7.5ml 0.1%レサズリン溶液 0.1ml 8%Na2CO3溶液 5ml 3%システイン塩酸塩溶液 1ml 寒天 2g 蒸留水 79ml (PH 6.8) ※溶液:前記希釈液に用いたものと同じ。 Glucose 0.2g Beef Extract (BBL) 0.2g Yeast Extract (Difco) 0.5g Tribute Case (BBL) 1g 0.1% K 2 HPO 4 Solution 7.5 ml Solution I * 7.5 ml 0.1% Resazurin Solution 0.1 ml 8% Na 2 CO 3 Solution 5ml 3% cysteine hydrochloride solution 1ml Agar 2g Distilled water 79ml (PH 6.8) *Solution: Same as the one used for the diluted solution above.
Claims (1)
るための成分として、グルコース、ラクトース、
フラクトースからなる群から選ばれた1種以上の
糖、アンモニウム塩、ビオチン、パントテン酸、
リボフラビン、ピルビン酸、ポリオキシエチレン
ソルビタンモノ脂肪酸エステル及びナリジクス酸
を含有する完全合成培地であることを特徴とする
ビフイドバクテリウム菌の選択培地。1 Glucose, lactose,
one or more sugars selected from the group consisting of fructose, ammonium salt, biotin, pantothenic acid,
A selective medium for Bifidobacterium, which is a completely synthetic medium containing riboflavin, pyruvate, polyoxyethylene sorbitan monofatty acid ester, and nalidixic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14634880A JPS5771390A (en) | 1980-10-21 | 1980-10-21 | Selective medium for bifidobacterium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14634880A JPS5771390A (en) | 1980-10-21 | 1980-10-21 | Selective medium for bifidobacterium |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5771390A JPS5771390A (en) | 1982-05-04 |
JPS6366518B2 true JPS6366518B2 (en) | 1988-12-21 |
Family
ID=15405668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14634880A Granted JPS5771390A (en) | 1980-10-21 | 1980-10-21 | Selective medium for bifidobacterium |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5771390A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0293025U (en) * | 1989-01-12 | 1990-07-24 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2147882C (en) * | 1992-10-27 | 2008-07-29 | Toshihiko Asano | Bifidobacterium growth promotant |
CN107805656B (en) * | 2017-12-14 | 2020-10-30 | 合生元(广州)健康产品有限公司 | Culture medium for detecting bifidobacteria and detection method |
-
1980
- 1980-10-21 JP JP14634880A patent/JPS5771390A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0293025U (en) * | 1989-01-12 | 1990-07-24 |
Also Published As
Publication number | Publication date |
---|---|
JPS5771390A (en) | 1982-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Newton et al. | The development of the anaerobic spoilage flora of meat stored at chill temperatures | |
Gerhardt | The nutrition of brucellae | |
Zahorchak et al. | Consequences of Ca2+ deficiency on macromolecular synthesis and adenylate energy charge in Yersinia pestis | |
Linton et al. | The effect of sublethal heat shock and growth atmosphere on the heat resistance of Listeria monocytogenes Scott A | |
Xu et al. | Spoilage lactic acid bacteria in the brewing industry | |
Tonin et al. | Beta-lactam-specific resistant mutants of Staphylococcus aureus | |
Peebles et al. | Preparation of concentrated lactic streptococcus starters | |
US4906573A (en) | Culture medium for detection of beer spoilage microorganisms | |
Kennes et al. | Trophic relationships between Saccharomyces cerevisiae and Lactobacillus plantarum and their metabolism of glucose and citrate | |
Vinopal et al. | New phosphoglucose isomerase mutants of Escherichia coli | |
Palmquist et al. | Enzymatic techniques for the study of pathways of carbohydrate utilization in the rumen | |
Tittsler et al. | Symposium on the lactic acid bacteria | |
JPS6366518B2 (en) | ||
Breidt et al. | Competitive growth of genetically marked malolactic-deficient Lactobacillus plantarum in cucumber fermentations | |
CA2055973C (en) | Fastidious organism supplement | |
PT1012225E (en) | Beer spoilage reducing methods and compositions | |
Pedersen et al. | Numbers and types of microorganisms in silage and effluent from grass ensiled with different additives | |
English et al. | Growth comparisons of streptomycin-sensitive and streptomycin-resistant Micrococcus pyogenes var. aureus | |
Schaefer | Effect of isoniazid on the dehydrogenase activity of Mycobacterium tuberculosis | |
US6037140A (en) | Selective media for the culture and isolation of gram bacteria, antibiotic composition | |
JP2563197B2 (en) | Bifidobacterium breve and food and drink | |
Teixeira | Lactobacillus: Lactobacillus brevis | |
US20060286625A1 (en) | Rapid enrichment for Listeria | |
US3616255A (en) | Method and dehydrated medium permitting easy detection of beer lactic acid bacteria | |
EP0104444A2 (en) | Fermentation method and compositions including a lactobacillus species strain |